MBNL1 and myotonic dystrophy type 1: A recent study conducted that chloroquine, a chemical inhibitor of autophagy, administration to DM1 models resulted in increased levels of MBNL1 and improved DM1 phenotypes in these models (Bargiela et al., 2019).